|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.76 USD | 0.00% |
|
-1.37% | -8.35% |
| Capitalization | 12.36B 10.53B 9.84B 9.25B 17.04B 1,120B 18.61B 115B 44.53B 528B 46.38B 45.4B 1,925B | P/E ratio 2025 * |
29.6x | P/E ratio 2026 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise value | 17.17B 14.63B 13.66B 12.86B 23.67B 1,555B 25.86B 159B 61.87B 733B 64.43B 63.07B 2,675B | EV / Sales 2025 * |
11.3x | EV / Sales 2026 * | 10.9x |
| Free-Float |
99.04% | Yield 2025 * |
4.21% | Yield 2026 * | 4.39% |
Last Transcript: Regency Centers Corporation
| 1 week | -1.37% | ||
| Current month | -4.78% | ||
| 1 month | -2.63% | ||
| 3 months | -5.02% | ||
| 6 months | -3.54% | ||
| Current year | -8.35% |
| 1 week | 67.1 | 68.95 | |
| 1 month | 67.1 | 71.88 | |
| Current year | 63.44 | 78.18 | |
| 1 year | 63.44 | 78.18 | |
| 3 years | 54.72 | 78.18 | |
| 5 years | 43.49 | 78.78 | |
| 10 years | 31.8 | 85.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lisa Palmer
CEO | Chief Executive Officer | 57 | 2019-12-31 |
Michael Mas
DFI | Director of Finance/CFO | 49 | 2019-08-11 |
Matt Lee
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Martin Stein
CHM | Chairman | 72 | 1997-12-31 |
C. Blankenship
BRD | Director/Board Member | 75 | 2000-12-31 |
Lisa Palmer
BRD | Director/Board Member | 57 | 2018-04-25 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -1.37% | -10.10% | +3.40% | 12.36B | ||
| +0.09% | -0.30% | +1.35% | +52.05% | 59.42B | ||
| +0.15% | +0.15% | -18.08% | -8.41% | 13.65B | ||
| -0.06% | +1.17% | +3.03% | -37.72% | 11.56B | ||
| +0.69% | -2.91% | -3.90% | +0.73% | 8.23B | ||
| -0.97% | +3.44% | +25.86% | +28.39% | 7.88B | ||
| +0.23% | +1.83% | -11.18% | +11.76% | 7.85B | ||
| +1.58% | +0.65% | -4.96% | -12.27% | 7.69B | ||
| +1.08% | +3.09% | -11.19% | +5.47% | 5.05B | ||
| +0.70% | +5.18% | -13.16% | +50.08% | 4.78B | ||
| Average | +0.34% | +1.01% | -4.23% | +9.35% | 13.85B | |
| Weighted average by Cap. | +0.19% | +0.22% | -2.38% | +22.24% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.52B 1.29B 1.21B 1.14B 2.09B 137B 2.28B 14.08B 5.46B 64.74B 5.69B 5.57B 236B | 1.57B 1.34B 1.25B 1.17B 2.16B 142B 2.36B 14.56B 5.65B 66.93B 5.88B 5.76B 244B |
| Net income | 423M 360M 336M 317M 583M 38.3B 637M 3.93B 1.52B 18.05B 1.59B 1.55B 65.87B | 457M 389M 364M 342M 630M 41.38B 688M 4.24B 1.65B 19.5B 1.71B 1.68B 71.16B |
| Net Debt | 4.81B 4.1B 3.83B 3.6B 6.63B 436B 7.24B 44.68B 17.33B 205B 18.05B 17.67B 749B | 4.75B 4.04B 3.78B 3.55B 6.54B 430B 7.15B 44.09B 17.1B 203B 17.81B 17.44B 739B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 67.76 $ | 0.00% | 1,015,329 |
| 25-12-11 | 67.76 $ | +0.83% | 1,702,144 |
| 25-12-10 | 67.20 $ | -0.87% | 1,714,330 |
| 25-12-09 | 67.79 $ | -0.12% | 848,250 |
| 25-12-08 | 67.87 $ | -1.21% | 971,861 |
Delayed Quote Nasdaq, December 12, 2025 at 04:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















